1
|
Thoresen D, Matsuda K, Urakami A, Ngwe Tun MM, Nomura T, Moi ML, Watanabe Y, Ishikawa M, Hau TTT, Yamamoto H, Suzaki Y, Ami Y, Smith JF, Matano T, Morita K, Akahata W. A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates. J Virol 2024; 98:e0023924. [PMID: 38647327 DOI: 10.1128/jvi.00239-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2024] [Accepted: 03/22/2024] [Indexed: 04/25/2024] Open
Abstract
Dengue virus (DENV) represents a significant global health burden, with 50% of the world's population at risk of infection, and there is an urgent need for next-generation vaccines. Virus-like particle (VLP)-based vaccines, which mimic the antigenic structure of the virus but lack the viral genome, are an attractive approach. Here, we describe a dengue VLP (DENVLP) vaccine which generates a neutralizing antibody response against all four DENV serotypes in 100% of immunized non-human primates for up to 1 year. Additionally, DENVLP vaccination produced no ADE response against any of four DENV serotypes in vitro. DENVLP vaccination reduces viral replication in a non-human primate challenge model. We also show that transfer of purified IgG from immunized monkeys into immunodeficient mice protects against subsequent lethal DENV challenge, indicating a humoral mechanism of protection. These results indicate that this DENVLP vaccine is immunogenic and can be considered for clinical evaluation. Immunization of non-human primates with a tetravalent DENVLP vaccine induces high levels of neutralizing antibodies and reduces the severity of infection for all four dengue serotypes.IMPORTANCEDengue is a viral disease that infects nearly 400 million people worldwide and causes dengue hemorrhagic fever, which is responsible for 10,000 deaths each year. Currently, there is no therapeutic drug licensed to treat dengue infection, which makes the development of an effective vaccine essential. Virus-like particles (VLPs) are a safe and highly immunogenic platform that can be used in young children, immunocompromised individuals, as well as healthy adults. In this study, we describe the development of a dengue VLP vaccine and demonstrate that it induces a robust immune response against the dengue virus for over 1 year in monkeys. The immunity induced by this vaccine reduced live dengue infection in both murine and non-human primate models. These results indicate that our dengue VLP vaccine is a promising vaccine candidate.
Collapse
Affiliation(s)
| | | | | | - Mya Myat Ngwe Tun
- Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Takushi Nomura
- AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
| | - Meng Ling Moi
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
- Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | | | | | - Trang Thi Thu Hau
- AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | - Hiroyuki Yamamoto
- AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | - Yuriko Suzaki
- Management Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan
| | - Yasushi Ami
- Management Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan
| | | | - Tetsuro Matano
- AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan
- Institute of Medical Science, University of Tokyo, Tokyo, Japan
| | - Kouichi Morita
- Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
- DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan
| | | |
Collapse
|
2
|
Aboshi M, Matsuda K, Kawakami D, Kono K, Kazami Y, Sekida T, Komori M, Morey AL, Suga S, Smith JF, Fukuhara T, Iwatani Y, Yamamoto T, Sato N, Akahata W. Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine. iScience 2024; 27:108964. [PMID: 38352232 PMCID: PMC10863314 DOI: 10.1016/j.isci.2024.108964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 11/15/2023] [Accepted: 01/15/2024] [Indexed: 02/16/2024] Open
Abstract
Continuing emergence of variants of concern resulting in reduced SARS-CoV-2 vaccine efficacy necessitates additional prevention strategies. The structure of VLPCOV-01, a lipid nanoparticle-encapsulated, self-amplifying RNA COVID-19 vaccine with a comparable immune response to BNT162b2, was revised by incorporating a modified base, 5-methylcytosine, to reduce reactogenicity, and an updated receptor-binding domain derived from the Brazil (gamma) variant. Interim analyses of a phase 1 dose-escalation booster vaccination study with the resulting construct, VLPCOV-02, in healthy, previously vaccinated Japanese individuals (N = 96) are reported (jRCT2051230005). A dose-related increase in solicited local and systemic adverse events was observed, which were generally rated mild or moderate. The most commonly occurring events were tenderness, pain, fatigue, and myalgia. Serum SARS-CoV-2 immunoglobulin titers increased during the 4 weeks post-immunization. VLPCOV-02 demonstrated a favorable safety profile compared with VLPCOV-01, with reduced adverse events and fewer fever events at an equivalent dose. These findings support further study of VLPCOV-02.
Collapse
Affiliation(s)
- Masayuki Aboshi
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | | | - Daisuke Kawakami
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | - Kaoru Kono
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | - Yoko Kazami
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | - Takashi Sekida
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | - Mai Komori
- VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA
| | | | - Shigeru Suga
- National Hospital Organization, Mie National Hospital, Tsu, Mie 514-0125, Japan
| | | | - Takasuke Fukuhara
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido 060-0815, Japan
- Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
| | - Yasumasa Iwatani
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi 460-0001, Japan
- Division of Basic Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Takuya Yamamoto
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan
| | - Nobuaki Sato
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| | - Wataru Akahata
- VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan
| |
Collapse
|
3
|
Komori M, Morey AL, Quiñones-Molina AA, Fofana J, Romero L, Peters E, Matsuda K, Gummuluru S, Smith JF, Akahata W, Akiyama H. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine. bioRxiv 2023:2023.11.01.565056. [PMID: 37961509 PMCID: PMC10634970 DOI: 10.1101/2023.11.01.565056] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2023]
Abstract
In order to improve vaccine effectiveness and safety profile of existing synthetic RNA-based vaccines, we have developed a self-amplifying RNA (saRNA)-based vaccine expressing membrane-anchored receptor binding domain (RBD) of SARS-CoV-2 S protein (S-RBD) and have demonstrated that a minimal dose of this saRNA vaccine elicits robust immune responses. Results from a recent clinical trial with 5-methylcytidine (5mC) incorporating saRNA vaccine demonstrated reduced vaccine-induced adverse effects while maintaining robust humoral responses. In this study, we investigate the mechanisms accounting for induction of efficient innate and adaptive immune responses and attenuated adverse effects induced by the 5mC-incorporated saRNA. We show that the 5mC-incorporating saRNA platform leads to prolonged and robust expression of antigen, while induction of type-I interferon (IFN-I), a key driver of reactogenicity, is attenuated in peripheral blood mononuclear cells (PBMCs), but not in macrophages and dendritic cells. Interestingly, we find that the major cellular source of IFN-I production in PBMCs is plasmacytoid dendritic cells (pDCs), which is attenuated upon 5mC incorporation in saRNA. In addition, we demonstrate that monocytes also play an important role in amplifying proinflammatory responses. Furthermore, we show that the detection of saRNA is mediated by a host cytosolic RNA sensor, RIG-I. Importantly, 5mC-incorporating saRNA vaccine candidate produced robust IgG responses against S-RBD upon injection in mice, thus providing strong support for the potential clinical use of 5mC-incorporating saRNA vaccines.
Collapse
|
4
|
Akahata W, Sekida T, Nogimori T, Ode H, Tamura T, Kono K, Kazami Y, Washizaki A, Masuta Y, Suzuki R, Matsuda K, Komori M, Morey AL, Ishimoto K, Nakata M, Hasunuma T, Fukuhara T, Iwatani Y, Yamamoto T, Smith JF, Sato N. Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study. Cell Rep Med 2023; 4:101134. [PMID: 37586325 PMCID: PMC10439244 DOI: 10.1016/j.xcrm.2023.101134] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 03/16/2023] [Accepted: 07/07/2023] [Indexed: 08/18/2023]
Abstract
VLPCOV-01 is a lipid nanoparticle-encapsulated self-amplifying RNA (saRNA) vaccine that expresses a membrane-anchored receptor-binding domain (RBD) derived from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. A phase 1 study of VLPCOV-01 is conducted (jRCT2051210164). Participants who completed two doses of the BNT162b2 mRNA vaccine previously are randomized to receive one intramuscular vaccination of 0.3, 1.0, or 3.0 μg VLPCOV-01, 30 μg BNT162b2, or placebo. No serious adverse events have been reported. VLPCOV-01 induces robust immunoglobulin G (IgG) titers against the RBD protein that are maintained up to 26 weeks in non-elderly participants, with geometric means ranging from 5,037 (95% confidence interval [CI] 1,272-19,940) at 0.3 μg to 12,873 (95% CI 937-17,686) at 3 μg compared with 3,166 (95% CI 1,619-6,191) with 30 μg BNT162b2. Neutralizing antibody titers against all variants of SARS-CoV-2 tested are induced. VLPCOV-01 is immunogenic following low-dose administration. These findings support the potential for saRNA as a vaccine platform.
Collapse
Affiliation(s)
- Wataru Akahata
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan.
| | - Takashi Sekida
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan
| | - Takuto Nogimori
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan
| | - Hirotaka Ode
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi 460-0001, Japan
| | - Tomokazu Tamura
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
| | - Kaoru Kono
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan
| | - Yoko Kazami
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan
| | - Ayaka Washizaki
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan
| | - Yuji Masuta
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan
| | - Rigel Suzuki
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
| | | | - Mai Komori
- VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA
| | | | | | - Misako Nakata
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan
| | - Tomoko Hasunuma
- Department of Research, Kitasato University, Kitasato Institute Hospital, Minato-ku, Tokyo 108-0072, Japan
| | - Takasuke Fukuhara
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
| | - Yasumasa Iwatani
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi 460-0001, Japan; Division of Basic Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan
| | - Takuya Yamamoto
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan
| | | | - Nobuaki Sato
- VLP Therapeutics Japan, Inc., Marunouchi, Minato-ku, Tokyo 105-0003, Japan
| |
Collapse
|
5
|
Komori M, Nogimori T, Morey AL, Sekida T, Ishimoto K, Hassett MR, Masuta Y, Ode H, Tamura T, Suzuki R, Alexander J, Kido Y, Matsuda K, Fukuhara T, Iwatani Y, Yamamoto T, Smith JF, Akahata W. saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nat Commun 2023; 14:2810. [PMID: 37208330 DOI: 10.1038/s41467-023-38457-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 04/27/2023] [Indexed: 05/21/2023] Open
Abstract
Several vaccines have been widely used to counteract the global pandemic caused by SARS-CoV-2. However, due to the rapid emergence of SARS-CoV-2 variants of concern (VOCs), further development of vaccines that confer broad and longer-lasting protection against emerging VOCs are needed. Here, we report the immunological characteristics of a self-amplifying RNA (saRNA) vaccine expressing the SARS-CoV-2 Spike (S) receptor binding domain (RBD), which is membrane-anchored by fusing with an N-terminal signal sequence and a C-terminal transmembrane domain (RBD-TM). Immunization with saRNA RBD-TM delivered in lipid nanoparticles (LNP) efficiently induces T-cell and B-cell responses in non-human primates (NHPs). In addition, immunized hamsters and NHPs are protected against SARS-CoV-2 challenge. Importantly, RBD-specific antibodies against VOCs are maintained for at least 12 months in NHPs. These findings suggest that this saRNA platform expressing RBD-TM will be a useful vaccine candidate inducing durable immunity against emerging SARS-CoV-2 strains.
Collapse
Affiliation(s)
- Mai Komori
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Takuto Nogimori
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka, 567-0085, Japan
| | - Amber L Morey
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Takashi Sekida
- VLP Therapeutics Japan, Inc. 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo, 100-0003, Japan
| | - Keiko Ishimoto
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Matthew R Hassett
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Yuji Masuta
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka, 567-0085, Japan
| | - Hirotaka Ode
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, 460-0001, Japan
| | - Tomokazu Tamura
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Hokkaido, 060-8638, Japan
| | - Rigel Suzuki
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Hokkaido, 060-8638, Japan
| | - Jeff Alexander
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Yasutoshi Kido
- Department of Virology & Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-0051, Japan
| | - Kenta Matsuda
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA
| | - Takasuke Fukuhara
- Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Hokkaido, 060-8638, Japan
| | - Yasumasa Iwatani
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, 460-0001, Japan
- Division of Basic Medicine, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan
| | - Takuya Yamamoto
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka, 567-0085, Japan.
- Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
- Department of Virology and Immunology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
| | - Jonathan F Smith
- VLP Therapeutics, Inc. 704 Quince Orchard Rd. #110, Gaithersburg, MD, 20878, USA.
| | - Wataru Akahata
- VLP Therapeutics Japan, Inc. 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo, 100-0003, Japan.
| |
Collapse
|
6
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Singh BSN, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. Publisher Correction: The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2020; 11:5185. [PMID: 33037232 PMCID: PMC7547707 DOI: 10.1038/s41467-020-19081-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva, 23 CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva, 23 CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104 MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva, 23 CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva, 23 CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
7
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Singh BSN, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. Addendum: The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2020; 11:3560. [PMID: 32661232 PMCID: PMC7359340 DOI: 10.1038/s41467-020-17309-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva, 23 CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva, 23 CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104, MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva, 23 CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva, 23 CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
8
|
Tang TL, Kay BP, Hoffman CR, Schiffer JP, Sharp DK, Gaffney LP, Freeman SJ, Mumpower MR, Arokiaraj A, Baader EF, Butler PA, Catford WN, de Angelis G, Flavigny F, Gott MD, Gregor ET, Konki J, Labiche M, Lazarus IH, MacGregor PT, Martel I, Page RD, Podolyák Z, Poleshchuk O, Raabe R, Recchia F, Smith JF, Szwec SV, Yang J. First Exploration of Neutron Shell Structure below Lead and beyond N=126. Phys Rev Lett 2020; 124:062502. [PMID: 32109128 DOI: 10.1103/physrevlett.124.062502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Revised: 12/12/2019] [Accepted: 01/02/2020] [Indexed: 06/10/2023]
Abstract
The nuclei below lead but with more than 126 neutrons are crucial to an understanding of the astrophysical r process in producing nuclei heavier than A∼190. Despite their importance, the structure and properties of these nuclei remain experimentally untested as they are difficult to produce in nuclear reactions with stable beams. In a first exploration of the shell structure of this region, neutron excitations in ^{207}Hg have been probed using the neutron-adding (d,p) reaction in inverse kinematics. The radioactive beam of ^{206}Hg was delivered to the new ISOLDE Solenoidal Spectrometer at an energy above the Coulomb barrier. The spectroscopy of ^{207}Hg marks a first step in improving our understanding of the relevant structural properties of nuclei involved in a key part of the path of the r process.
Collapse
Affiliation(s)
- T L Tang
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - B P Kay
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - C R Hoffman
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J P Schiffer
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D K Sharp
- Department of Physics, University of Manchester, M13 9PL Manchester, United Kingdom
| | | | - S J Freeman
- Department of Physics, University of Manchester, M13 9PL Manchester, United Kingdom
| | - M R Mumpower
- Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
- Center for Theoretical Astrophysics, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A Arokiaraj
- KU Leuven, Intituut voor Kern-en Stralingsfysica, Celestijnenlaan 200D, 3001 Leuven, Belgium
| | | | - P A Butler
- Oliver Lodge Laboratory, University of Liverpool, L69 7ZE Liverpool, United Kingdom
| | - W N Catford
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - G de Angelis
- Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro, I-35020 Legnaro, Italy
| | - F Flavigny
- Institut de Physique Nucléaire, CNRS-IN2P3, Université Paris-Sud, Université Paris-Saclay, 91406 Orsay, France
- LPC Caen, Normandie Université, ENSICAEN, UNICAEN, CNRS/IN2P3, 14000 Caen, France
| | - M D Gott
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - E T Gregor
- Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro, I-35020 Legnaro, Italy
| | - J Konki
- CERN, CH-1211 Geneva, Switzerland
| | - M Labiche
- Nuclear Physics Group, UKRI-STFC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom
| | - I H Lazarus
- Nuclear Physics Group, UKRI-STFC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom
| | - P T MacGregor
- Department of Physics, University of Manchester, M13 9PL Manchester, United Kingdom
| | - I Martel
- Oliver Lodge Laboratory, University of Liverpool, L69 7ZE Liverpool, United Kingdom
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, L69 7ZE Liverpool, United Kingdom
| | - Zs Podolyák
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - O Poleshchuk
- KU Leuven, Intituut voor Kern-en Stralingsfysica, Celestijnenlaan 200D, 3001 Leuven, Belgium
| | - R Raabe
- KU Leuven, Intituut voor Kern-en Stralingsfysica, Celestijnenlaan 200D, 3001 Leuven, Belgium
| | - F Recchia
- Dipartimento di Fisica e Astronomia, Universit degli Studi di Padova, I-35131 Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - J F Smith
- SUPA, School of Computing, Engineering, and Physical Sciences, University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - S V Szwec
- Department of Physics, University of Jyvaskyla, P.O. Box 35, FI-40014 Jyvaskyla, Finland
- Helsinki Institute of Physics, University of Helsinki, FIN-00014 Helsinki, Finland
| | - J Yang
- KU Leuven, Intituut voor Kern-en Stralingsfysica, Celestijnenlaan 200D, 3001 Leuven, Belgium
| |
Collapse
|
9
|
Butler PA, Gaffney LP, Spagnoletti P, Abrahams K, Bowry M, Cederkäll J, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Konki J, Kröll T, Lozano M, Nara Singh BS, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Scheck M, Seidlitz M, Shneidman TM, Siebeck B, Sinclair J, Smith JF, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielińska M. Evolution of Octupole Deformation in Radium Nuclei from Coulomb Excitation of Radioactive ^{222}Ra and ^{228}Ra Beams. Phys Rev Lett 2020; 124:042503. [PMID: 32058764 DOI: 10.1103/physrevlett.124.042503] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2019] [Indexed: 06/10/2023]
Abstract
There is sparse direct experimental evidence that atomic nuclei can exhibit stable "pear" shapes arising from strong octupole correlations. In order to investigate the nature of octupole collectivity in radium isotopes, electric octupole (E3) matrix elements have been determined for transitions in ^{222,228}Ra nuclei using the method of sub-barrier, multistep Coulomb excitation. Beams of the radioactive radium isotopes were provided by the HIE-ISOLDE facility at CERN. The observed pattern of E3 matrix elements for different nuclear transitions is explained by describing ^{222}Ra as pear shaped with stable octupole deformation, while ^{228}Ra behaves like an octupole vibrator.
Collapse
Affiliation(s)
- P A Butler
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L P Gaffney
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - P Spagnoletti
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - K Abrahams
- University of the Western Cape, Private Bag X17, Bellville 7535, South Africa
| | - M Bowry
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
- TRIUMF, Vancouver V6T 2A3 BC, Canada
| | - J Cederkäll
- Lund University, Box 118, Lund SE-221 00, Sweden
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro 35020 PD, Italy
| | | | - P E Garrett
- University of Guelph, Guelph N1G 2W1 Ontario, Canada
| | - A Goldkuhle
- University of Cologne, Cologne 50937, Germany
| | - C Henrich
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro 35020 PD, Italy
| | - K Johnston
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - D T Joss
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J M Keatings
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - N A Kelly
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw PL-02-093, Poland
| | - J Konki
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - T Kröll
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - M Lozano
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - B S Nara Singh
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - D O'Donnell
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - J Ojala
- University of Jyvaskyla, P.O. Box 35, Jyvaskyla FIN-40014, Finland
- Helsinki Institute of Physics, P.O. Box 64, Helsinki FIN-00014, Finland
| | - R D Page
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L G Pedersen
- University of Oslo, P.O. Box 1048, Oslo N-0316, Norway
| | - C Raison
- University of York, York YO10 5DD, United Kingdom
| | - P Reiter
- University of Cologne, Cologne 50937, Germany
| | | | - D Rosiak
- University of Cologne, Cologne 50937, Germany
| | - S Rothe
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - M Scheck
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - M Seidlitz
- University of Cologne, Cologne 50937, Germany
| | - T M Shneidman
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russian Federation
| | - B Siebeck
- University of Cologne, Cologne 50937, Germany
| | - J Sinclair
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - J F Smith
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | | | | | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid S28040, Spain
| | - V Virtanen
- University of Jyvaskyla, P.O. Box 35, Jyvaskyla FIN-40014, Finland
- Helsinki Institute of Physics, P.O. Box 64, Helsinki FIN-00014, Finland
| | - N Warr
- University of Cologne, Cologne 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw PL-02-093, Poland
| | - M Zielińska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette F-91191, France
| |
Collapse
|
10
|
Banerjee K, Hinde DJ, Dasgupta M, Simpson EC, Jeung DY, Simenel C, Swinton-Bland BMA, Williams E, Carter IP, Cook KJ, David HM, Düllmann CE, Khuyagbaatar J, Kindler B, Lommel B, Prasad E, Sengupta C, Smith JF, Vo-Phuoc K, Walshe J, Yakushev A. Mechanisms Suppressing Superheavy Element Yields in Cold Fusion Reactions. Phys Rev Lett 2019; 122:232503. [PMID: 31298876 DOI: 10.1103/physrevlett.122.232503] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Revised: 10/17/2018] [Indexed: 06/10/2023]
Abstract
Superheavy elements are formed in fusion reactions which are hindered by fast nonequilibrium processes. To quantify these, mass-angle distributions and cross sections have been measured, at beam energies from below-barrier to 25% above, for the reactions of ^{48}Ca, ^{50}Ti, and ^{54}Cr with ^{208}Pb. Moving from ^{48}Ca to ^{54}Cr leads to a drastic fall in the symmetric fission yield, which is reflected in the measured mass-angle distribution by the presence of competing fast nonequilibrium deep inelastic and quasifission processes. These are responsible for reduction of the compound nucleus formation probablity P_{CN} (as measured by the symmetric-peaked fission cross section), by a factor of 2.5 for ^{50}Ti and 15 for ^{54}Cr in comparison to ^{48}Ca. The energy dependence of P_{CN} indicates that cold fusion reactions (involving ^{208}Pb) are not driven by a diffusion process.
Collapse
Affiliation(s)
- K Banerjee
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - D J Hinde
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - M Dasgupta
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - E C Simpson
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - D Y Jeung
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - C Simenel
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - B M A Swinton-Bland
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - E Williams
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - I P Carter
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - K J Cook
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - H M David
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - Ch E Düllmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- Institut für Kernchemie, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Khuyagbaatar
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| | - B Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - E Prasad
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - C Sengupta
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - J F Smith
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - K Vo-Phuoc
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - J Walshe
- Department of Nuclear Physics, Research School of Physics and Engineering, The Australian National University, Canberra ACT 2601, Australia
| | - A Yakushev
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| |
Collapse
|
11
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Nara Singh BS, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2019; 10:2473. [PMID: 31171788 PMCID: PMC6554308 DOI: 10.1038/s41467-019-10494-5] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 05/15/2019] [Indexed: 11/09/2022] Open
Abstract
There is a large body of evidence that atomic nuclei can undergo octupole distortion and assume the shape of a pear. This phenomenon is important for measurements of electric-dipole moments of atoms, which would indicate CP violation and hence probe physics beyond the Standard Model of particle physics. Isotopes of both radon and radium have been identified as candidates for such measurements. Here, we observed the low-lying quantum states in 224Rn and 226Rn by accelerating beams of these radioactive nuclei. We show that radon isotopes undergo octupole vibrations but do not possess static pear-shapes in their ground states. We conclude that radon atoms provide less favourable conditions for the enhancement of a measurable atomic electric-dipole moment.
Collapse
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva 23, CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva 23, CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104, MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020, PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020, PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva 23, CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva 23, CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
12
|
Bree N, Wrzosek-Lipska K, Petts A, Andreyev A, Bastin B, Bender M, Blazhev A, Bruyneel B, Butler PA, Butterworth J, Carpenter MP, Cederkäll J, Clément E, Cocolios TE, Deacon A, Diriken J, Ekström A, Fitzpatrick C, Fraile LM, Fransen C, Freeman SJ, Gaffney LP, García-Ramos JE, Geibel K, Gernhäuser R, Grahn T, Guttormsen M, Hadinia B, Hadyńska-Kle K K, Hass M, Heenen PH, Herzberg RD, Hess H, Heyde K, Huyse M, Ivanov O, Jenkins DG, Julin R, Kesteloot N, Kröll T, Krücken R, Larsen AC, Lutter R, Marley P, Napiorkowski PJ, Orlandi R, Page RD, Pakarinen J, Patronis N, Peura PJ, Piselli E, Rahkila P, Rapisarda E, Reiter P, Robinson AP, Scheck M, Siem S, Singh Chakkal K, Smith JF, Srebrny J, Stefanescu I, Tveten GM, Van Duppen P, Van de Walle J, Voulot D, Warr N, Wenander F, Wiens A, Wood JL, Zielińska M. Shape coexistence in the neutron-deficient even-even (182-188)Hg isotopes studied via coulomb excitation. Phys Rev Lett 2014; 112:162701. [PMID: 24815644 DOI: 10.1103/physrevlett.112.162701] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2013] [Indexed: 06/03/2023]
Abstract
Coulomb-excitation experiments to study electromagnetic properties of radioactive even-even Hg isotopes were performed with 2.85 MeV/nucleon mercury beams from REX-ISOLDE. Magnitudes and relative signs of the reduced E2 matrix elements that couple the ground state and low-lying excited states in Hg182-188 were extracted. Information on the deformation of the ground and the first excited 0+ states was deduced using the quadrupole sum rules approach. Results show that the ground state is slightly deformed and of oblate nature, while a larger deformation for the excited 0+ state was noted in Hg182,184. The results are compared to beyond mean field and interacting-boson based models and interpreted within a two-state mixing model. Partial agreement with the model calculations was obtained. The presence of two different structures in the light even-mass mercury isotopes that coexist at low excitation energy is firmly established.
Collapse
Affiliation(s)
- N Bree
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium
| | - K Wrzosek-Lipska
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Heavy Ion Laboratory, University of Warsaw, PL-02-093 Warsaw, Poland
| | - A Petts
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Andreyev
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Department of Physics, University of York, York YO10 5DD, United Kingdom
| | - B Bastin
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and GANIL CEA/DSM-CNRS/IN2P3, Boulevard H. Becquerel, F-14076 Caen, France
| | - M Bender
- Université Bordeaux, Centre d'Etudes Nucléaires de Bordeaux Gradignan, UMR5797, F-33175 Gradignan, France and CNRS/IN2P3, Centre d'Etudes Nucléaires de Bordeaux Gradignan, UMR5797, F-33175 Gradignan, France
| | - A Blazhev
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - B Bruyneel
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J Butterworth
- Department of Physics, University of York, York YO10 5DD, United Kingdom
| | - M P Carpenter
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J Cederkäll
- Physics Department, University of Lund, Box 118, SE-221 00 Lund, Sweden and ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - E Clément
- GANIL CEA/DSM-CNRS/IN2P3, Boulevard H. Becquerel, F-14076 Caen, France and ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - T E Cocolios
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and ISOLDE, CERN, CH-1211 Geneva 23, Switzerland and School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - A Deacon
- School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - J Diriken
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Belgian Nuclear Research Centre SCK CEN, B-2400 Mol, Belgium
| | - A Ekström
- Physics Department, University of Lund, Box 118, SE-221 00 Lund, Sweden
| | - C Fitzpatrick
- School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - L M Fraile
- ISOLDE, CERN, CH-1211 Geneva 23, Switzerland and Grupo de Física Nuclear, Universidad Complutense de Madrit, 28040 Madrid, Spain
| | - Ch Fransen
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - S J Freeman
- School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - L P Gaffney
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J E García-Ramos
- Departamento de Física Aplicada, Universidad de Huelva, 21071 Huelva, Spain
| | - K Geibel
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - R Gernhäuser
- Physics Department E12, Technische Universität München, D-85748 Garching, Germany
| | - T Grahn
- Department of Physics, University of Jyväskylä, P.O. Box 35, FI-40014 Jyväskylä, Finland and Helsinki Institute of Physics, University of Helsinki, P.O. Box 64, FIN-00014 Helsinki, Finland
| | - M Guttormsen
- Department of Physics, University of Oslo, N-0316 Oslo, Norway
| | - B Hadinia
- School of Engineering, University of the West of Scotland, Paisley PA1 2BE, United Kingdom and Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - K Hadyńska-Kle K
- Heavy Ion Laboratory, University of Warsaw, PL-02-093 Warsaw, Poland
| | - M Hass
- Department of Particle Physics, Weizmann Institute of Science, Rehovot 76100, Israel
| | - P-H Heenen
- Physique Nucléaire Théorique, Université Libre de Bruxelles, B-1050 Bruxelles, Belgium
| | - R-D Herzberg
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - H Hess
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - K Heyde
- Department of Physics and Astronomy, Ghent University, B-9000 Gent, Belgium
| | - M Huyse
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium
| | - O Ivanov
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium
| | - D G Jenkins
- Department of Physics, University of York, York YO10 5DD, United Kingdom
| | - R Julin
- Department of Physics, University of Jyväskylä, P.O. Box 35, FI-40014 Jyväskylä, Finland
| | - N Kesteloot
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Belgian Nuclear Research Centre SCK CEN, B-2400 Mol, Belgium
| | - Th Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, D-64289 Darmstadt, Germany
| | - R Krücken
- Physics Department E12, Technische Universität München, D-85748 Garching, Germany
| | - A C Larsen
- Department of Physics, University of Oslo, N-0316 Oslo, Norway
| | - R Lutter
- Department of Physics, Ludwig Maximilian Universität München, 85748 Garching, Germany
| | - P Marley
- Department of Physics, University of York, York YO10 5DD, United Kingdom
| | - P J Napiorkowski
- Heavy Ion Laboratory, University of Warsaw, PL-02-093 Warsaw, Poland
| | - R Orlandi
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and School of Engineering, University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J Pakarinen
- Department of Physics, University of Jyväskylä, P.O. Box 35, FI-40014 Jyväskylä, Finland and Helsinki Institute of Physics, University of Helsinki, P.O. Box 64, FIN-00014 Helsinki, Finland
| | - N Patronis
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Department of Physics, The University of Ioannina, GR-45110 Ioannina, Greece
| | - P J Peura
- Department of Physics, University of Jyväskylä, P.O. Box 35, FI-40014 Jyväskylä, Finland
| | - E Piselli
- ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - P Rahkila
- Department of Physics, University of Jyväskylä, P.O. Box 35, FI-40014 Jyväskylä, Finland
| | - E Rapisarda
- ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - P Reiter
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - A P Robinson
- Department of Physics, University of York, York YO10 5DD, United Kingdom and School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, United Kingdom
| | - M Scheck
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom and School of Engineering, University of the West of Scotland, Paisley PA1 2BE, United Kingdom and SUPA, Scottisch Universities Physics Alliance, Glasgow G12 8QQ, United Kingdom
| | - S Siem
- Department of Physics, University of Oslo, N-0316 Oslo, Norway
| | - K Singh Chakkal
- Department of Particle Physics, Weizmann Institute of Science, Rehovot 76100, Israel
| | - J F Smith
- School of Engineering, University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - J Srebrny
- Heavy Ion Laboratory, University of Warsaw, PL-02-093 Warsaw, Poland
| | - I Stefanescu
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium and Physics Department E12, Technische Universität München, D-85748 Garching, Germany
| | - G M Tveten
- Department of Physics, University of Oslo, N-0316 Oslo, Norway
| | - P Van Duppen
- KU Leuven, Instituut voor Kern- en Stralingsfysica, B-3001 Leuven, Belgium
| | | | - D Voulot
- ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - N Warr
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - F Wenander
- ISOLDE, CERN, CH-1211 Geneva 23, Switzerland
| | - A Wiens
- Institut für Kernphysik, Universität zu Köln, 50937 Köln, Germany
| | - J L Wood
- School of Physics, Georgia Institute of Technology, Atlanta, Georgia 30332-0430, USA
| | - M Zielińska
- Heavy Ion Laboratory, University of Warsaw, PL-02-093 Warsaw, Poland and IRFU/SPhN, CEA Saclay, F-91191 Gif-sur-Yvette, France
| |
Collapse
|
13
|
Brake DW, Titgemeyer EC, Brouk MJ, Macgregor CA, Smith JF, Bradford BJ. Availability to lactating dairy cows of methionine added to soy lecithins and mixed with a mechanically extracted soybean meal. J Dairy Sci 2013; 96:3064-74. [PMID: 23498012 DOI: 10.3168/jds.2012-6005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2012] [Accepted: 01/22/2013] [Indexed: 12/16/2023]
Abstract
We evaluated a product containing methionine mixed with soy lecithins and added to a mechanically extracted soybean meal (meSBM-Met). Lactational responses of cows, plasma methionine concentrations, and in vitro degradation of methionine were measured. Twenty-five Holstein cows were used in a replicated 5 × 5 Latin square design and fed a diet designed to be deficient in methionine or the same diet supplemented either with 4.2 or 8.3g/d of supplemental methionine from a ruminally protected source or with 2.7 or 5.3g/d of supplemental methionine from meSBM-Met. All diets were formulated to provide adequate amounts of metabolizable lysine. Concentration of milk true protein was greater when methionine was provided by the ruminally protected methionine than by meSBM-Met, but milk protein yield was not affected by treatment. Milk yields and concentrations and yields of fat, lactose, solids-not-fat, and milk urea nitrogen were not affected by supplemental methionine. Body condition scores increased linearly when methionine from meSBM-Met was supplemented, but responses were quadratic when methionine was provided from a ruminally protected source. Nitrogen retention was not affected by supplemental methionine. Plasma methionine increased linearly when methionine was supplemented from a ruminally protected source, but plasma methionine concentrations did not differ from the control when supplemental methionine from meSBM-Met was provided. In vitro degradation of supplemental methionine from meSBM-Met was complete within 3h. Data suggest that meSBM-Met provides negligible amounts of metabolizable methionine to dairy cows, and this is likely related to extensive ruminal destruction of methionine; however, cow body condition may be improved by ruminally available methionine provided by meSBM-Met.
Collapse
Affiliation(s)
- D W Brake
- Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506, USA
| | | | | | | | | | | |
Collapse
|
14
|
Smith JF, Catchot AL, Musser FR, Gore J. Effects of aldicarb and neonicotinoid seed treatments on twospotted spider mite on cotton. J Econ Entomol 2013; 106:807-815. [PMID: 23786068 DOI: 10.1603/ec10125] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Twelve field experiments and one laboratory experiment were conducted to determine the effects of furrow applied aldicarb and seed treatments of thiamethoxam, imidacloprid, Avicta (thiamethoxam + abamectin), Aeris (imidacloprid + thiodicarb), and acephate on twospotted spider mite, Tetranychus urticae Koch, on cotton, Cossypium hirsutum L. For the field experiments, data were pooled across all experiments for analysis. Aeris, thiamethoxam, and imidacloprid treatments resulted in twospotted spider mite densities greater than those in the untreated check, aldicarb, and acephate treatments. However, cotton treated with Avicta (thiamethoxam + abamectin) had 34% fewer mites than other neonicotinoid seed treatments when infestations occurred near cotyledon stage. Untreated check and aldicarb treatments had the lowest mite densities. Only aldicarb reduced mite densities below that in the untreated check. In a laboratory trial, the fecundity of twospotted spider mite was measured. While neonicotinoid seed treatments increased mite densities in the field, they did not increase fecundity in the laboratory experiment. Foliar applied thiamethoxam slightly elevated average fecundity in the laboratory experiment. Increased use of neonicotinoid seed treatments instead of furrow applied aldicarb is likely at least partly responsible for recent increased twospotted spider mite infestations in seedling cotton across the mid-south.
Collapse
Affiliation(s)
- J F Smith
- Bayer CropScience, 358 Glenwood Drive, Monticello, AR 71655, USA.
| | | | | | | |
Collapse
|
15
|
Walsh TJ, Hotaling JM, Lue TF, Smith JF. How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. Int J Impot Res 2013; 25:109-12. [PMID: 23344164 DOI: 10.1038/ijir.2012.48] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Peyronie's disease (PD) is caused by progressive fibrotic scarring of the tunica albuginea resulting in curvature or other deformities of the erect penis. The severity of penile curvature or other deformity may contribute to a man's inability to have intercourse (sexual disability), due to difficulty with penetration, partner pain or emotional stress. To determine whether the degree of curvature or type of penile deformity predicts sexual disability among men with PD. This cross-sectional analysis of consecutive men evaluated for PD at a single tertiary referral center used a PD-specific questionnaire to evaluate risk factors for sexual disability in men with PD, who did not have erectile dysfunction (ED). Multivariate logistic regression was used to determine the clinical predictors of sexual disability. Sexual disability as defined by the inability to have penetrative intercourse. A total of 202 men were evaluated and 88 men with ED were excluded. Sexual disability was associated with relationship problems, penile curvature and penile length loss in bivariate, but not multivariate analysis. We found that although many of the demographic, medical and sexual function domains were significant predictors of inability to have sex, the only significant predictor of sexual disability in multivariate analysis was curvature>60° (odds ratio 3.23 95%CI 1.08-9.67). PD can be sexually disabling in many men without ED. Severe penile curvature is a robust independent predictor of the ability to have intercourse. Other penile deformities fail to predict sexual disability. This is important for counseling patients with newly diagnosed PD and those who are considering medical or surgical intervention.
Collapse
Affiliation(s)
- T J Walsh
- Department of Urology, University of Washington School of Medicine, Seattle, WA 98195-6510, USA.
| | | | | | | |
Collapse
|
16
|
Hansen RP, Smith JF. The occurrence of methyl methoxystearate isomers in the methyl esters prepared from sheep perinephric fat. Lipids 2012; 1:316-21. [PMID: 17805594 DOI: 10.1007/bf02532673] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/1966] [Indexed: 10/23/2022]
Abstract
A fraction has been isolated from sheep perinephric fat and identified by techniques which included mass and infrared spectrometry, as a mixture of the 8 to 14-methoxyoctadecanoic acid isomers. It is postulated that these isomers are artifacts produced by rigorous esterification with methanol and concentrated H(2)SO(4) of a large sample of sheep perinephric fatty acids which are presumed to have contained trace amounts of constituent hydroxy fatty acids. It is estimated that these methoxystearic acid isomers represented approximately 0.08% of the total weight of fatty acids.
Collapse
Affiliation(s)
- R P Hansen
- Food Chemistry Division, Department of Scientific and Industrial Research, Wellington, New Zealand
| | | |
Collapse
|
17
|
Paredes E, Adams SL, Tervit HR, Smith JF, McGowan LT, Gale SL, Morrish JR, Watts E. Cryopreservation of Greenshell™ mussel (Perna canaliculus) trochophore larvae. Cryobiology 2012; 65:256-62. [PMID: 22885548 DOI: 10.1016/j.cryobiol.2012.07.078] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2012] [Revised: 07/24/2012] [Accepted: 07/24/2012] [Indexed: 11/19/2022]
Abstract
The Greenshell™ mussel (Perna canaliculus) is the main shellfish species farmed in New Zealand. The aim of this study was to evaluate the effects of cryoprotectant concentration, loading and unloading strategy as well as freezing and thawing method in order to develop a protocol for cryopreservation of trochophore larvae (16-20 h old). Toxicity tests showed that levels of 10-15% ethylene glycol (EG) were not toxic to larvae and could be loaded and unloaded in a single step. Through cryopreservation experiments, we designed a cryopreservation protocol that enabled 40-60% of trochophores to develop to D-larvae when normalized to controls. The protocol involved: holding at 0 °C for 5 min, then cooling at 1 °C min⁻¹ to -10 °C, holding for a further 5 min, then cooling at 0.5 °C min⁻¹ to -35 °C followed by a 5 min hold and then plunging into liquid nitrogen. A final larval rearing experiment of 18 days was conducted to assess the ability of these frozen larvae to develop further. Results showed that only 2.8% of the frozen trochophores were able to develop to competent pediveligers.
Collapse
Affiliation(s)
- E Paredes
- Departamento de Ecoloxía e Bioloxía Animal, Universidade de Vigo, Estrada Colwxio Universitario s/n, 36310 Vigo, Galicia, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Wimmer K, Kröll T, Krücken R, Bildstein V, Gernhäuser R, Bastin B, Bree N, Diriken J, Van Duppen P, Huyse M, Patronis N, Vermaelen P, Voulot D, Van de Walle J, Wenander F, Fraile LM, Chapman R, Hadinia B, Orlandi R, Smith JF, Lutter R, Thirolf PG, Labiche M, Blazhev A, Kalkühler M, Reiter P, Seidlitz M, Warr N, Macchiavelli AO, Jeppesen HB, Fiori E, Georgiev G, Schrieder G, Das Gupta S, Lo Bianco G, Nardelli S, Butterworth J, Johansen J, Riisager K. Discovery of the shape coexisting 0+ state in 32 Mg by a two neutron transfer reaction. Phys Rev Lett 2010; 105:252501. [PMID: 21231582 DOI: 10.1103/physrevlett.105.252501] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/05/2010] [Indexed: 05/30/2023]
Abstract
The "island of inversion" nucleus 32 Mg has been studied by a (t, p) two neutron transfer reaction in inverse kinematics at REX-ISOLDE. The shape coexistent excited 0+ state in 32 Mg has been identified by the characteristic angular distribution of the protons of the Δ L=0 transfer. The excitation energy of 1058 keV is much lower than predicted by any theoretical model. The low γ-ray intensity observed for the decay of this 0+ state indicates a lifetime of more than 10 ns. Deduced spectroscopic amplitudes are compared with occupation numbers from shell-model calculations.
Collapse
Affiliation(s)
- K Wimmer
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Brown DT, Smith JF. Morphology of BHK-21 Cells Infected with Sindbis Virus Temperature-Sensitive Mutants in Complementation Groups D and E. J Virol 2010; 15:1262-6. [PMID: 16789157 PMCID: PMC354582 DOI: 10.1128/jvi.15.5.1262-1266.1975] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
BHK-21 cells infected with temperature-sensitive mutants of Sindbis virus in complementation groups D and E differed in their appearance under nonpermissive conditions. Cells infected at nonpermissive temperature with virus defective in complementation group E had nucleocapsids attached in large numbers to the inside surface of the host plasma membrane. Infection with a group D mutant produced nucleocapsids that did not attach to the plasma membrane but rather remained free in the cell cytoplasm.
Collapse
Affiliation(s)
- D T Brown
- Institut fũr Genetik der Universitãt zu Kõln, 5 Kõln 41, Weyertal 121, West Germany
| | | |
Collapse
|
20
|
Capps JA, Smith JF. EXPERIMENTS ON THE LEUKOLYTIC ACTION OF THE BLOOD SERUM OF CASES OF LEUKAEMIA TREATED WITH X-RAY AND THE INJECTION OF HUMAN LEUKOLYTIC SERUM IN A CASE OF LEUKAEMIA. ACTA ACUST UNITED AC 2010; 9:51-63. [PMID: 19867072 PMCID: PMC2124653 DOI: 10.1084/jem.9.1.51] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- J A Capps
- Pathological Laboratory of Rush Medical College, Chicago, III
| | | |
Collapse
|
21
|
Kamrud KI, Alterson K, Custer M, Dudek J, Goodman C, Owens G, Smith JF. Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. J Gen Virol 2010; 91:1723-7. [PMID: 20181749 PMCID: PMC2888770 DOI: 10.1099/vir.0.020081-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Alphavirus-based replicon systems are frequently used as preclinical vectors and as antigen discovery tools, and they have recently been assessed in clinical vaccine trials. Typically, alphavirus replicon RNAs are delivered within virus-like replicon particles (VRP) that are produced following transfection of replicon RNA and two helper RNAs into permissive cells in vitro. The non-structural proteins expressed from the replicon RNA amplify the replicon RNA in cis and the helper RNAs in trans, the latter providing the viral structural proteins necessary to package the replicon RNA into VRP. Current helper RNA designs incorporate the alphavirus 26S promoter to direct the transcription of high levels of structural gene mRNAs. We demonstrate here that the 26S promoter is not required on helper RNAs to produce VRP and propose that such promoterless helper RNAs, by design, reduce the probability of generating replication-competent virus that may otherwise result from RNA recombination.
Collapse
Affiliation(s)
- K I Kamrud
- AlphaVax, Inc., 2 Triangle Drive, Research Triangle Park, NC 27709, USA.
| | | | | | | | | | | | | |
Collapse
|
22
|
Hooper JW, Ferro AM, Golden JW, Silvera P, Dudek J, Alterson K, Custer M, Rivers B, Morris J, Owens G, Smith JF, Kamrud KI. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 2009; 28:494-511. [PMID: 19833247 DOI: 10.1016/j.vaccine.2009.09.133] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2009] [Revised: 09/18/2009] [Accepted: 09/30/2009] [Indexed: 11/27/2022]
Abstract
Naturally occurring smallpox was eradicated as a result of successful vaccination campaigns during the 1960s and 1970s. Because of its highly contagious nature and high mortality rate, smallpox has significant potential as a biological weapon. Unfortunately, the current vaccine for orthopoxviruses is contraindicated for large portions of the population. Thus, there is a need for new, safe, and effective orthopoxvirus vaccines. Alphavirus replicon vectors, derived from strains of Venezuelan equine encephalitis virus, are being used to develop alternatives to the current smallpox vaccine. Here, we demonstrated that virus-like replicon particles (VRPs) expressing the vaccinia virus A33R, B5R, A27L, and L1R genes elicited protective immunity in mice comparable to vaccination with live-vaccinia virus. Furthermore, cynomolgus macaques vaccinated with a combination of the four poxvirus VRPs (4pox-VRP) developed antibody responses to each antigen. These antibody responses were able to neutralize and inhibit the spread of both vaccinia virus and monkeypox virus. Macaques vaccinated with 4pox-VRP, flu HA VRP (negative control), or live-vaccinia virus (positive control) were challenged intravenously with 5 x 10(6)pfu of monkeypox virus 1 month after the second VRP vaccination. Four of the six negative control animals succumbed to monkeypox and the remaining two animals demonstrated either severe or grave disease. Importantly, all 10 macaques vaccinated with the 4pox-VRP vaccine survived without developing severe disease. These findings revealed that a single-boost VRP smallpox vaccine shows promise as a safe alternative to the currently licensed live-vaccinia virus smallpox vaccine.
Collapse
Affiliation(s)
- Jay W Hooper
- US Army Medical Research Institute of Infectious Diseases, Virology Division, 1425 Porter Street, Fort Detrick, MD 21702, United States.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Smith JF, Chen K, Horwitz B, Alexander GE. Temporal Evolution of Performance Related Regional Networks for Visual-to-Auditory Memory. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)71193-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
24
|
Valiente-Dobón JJ, Mengoni D, Gadea A, Farnea E, Lenzi SM, Lunardi S, Dewald A, Pissulla T, Szilner S, Broda R, Recchia F, Algora A, Angus L, Bazzacco D, Benzoni G, Bizzeti PG, Bizzeti-Sona AM, Boutachkov P, Corradi L, Crespi F, de Angelis G, Fioretto E, Görgen A, Gorska M, Gottardo A, Grodner E, Guiot B, Howard A, Królas W, Leoni S, Mason P, Menegazzo R, Montanari D, Montagnoli G, Napoli DR, Obertelli A, Pawłat T, Pollarolo G, Rubio B, Sahin E, Scarlassara F, Silvestri R, Stefanini AM, Smith JF, Steppenbeck D, Ur CA, Wady PT, Wrzesiński J, Maglione E, Hamamoto I. Lifetime measurements of the neutron-rich N = 30 isotones 50Ca and 51Sc: orbital dependence of effective charges in the fp shell. Phys Rev Lett 2009; 102:242502. [PMID: 19659003 DOI: 10.1103/physrevlett.102.242502] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/02/2008] [Indexed: 05/28/2023]
Abstract
The lifetimes of the first excited states of the N = 30 isotones (50)Ca and (51)Sc have been determined using the Recoil Distance Doppler Shift method in combination with the CLARA-PRISMA spectrometers. This is the first time such a method is applied to measure lifetimes of neutron-rich nuclei populated via a multinucleon transfer reaction. This extends the lifetime knowledge beyond the f_{7/2} shell closure and allows us to derive the effective proton and neutron charges in the fp shell near the doubly magic nucleus (48)Ca, using large-scale, shell-model calculations. These results indicate an orbital dependence of the core polarization along the fp shell.
Collapse
Affiliation(s)
- J J Valiente-Dobón
- Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro, Legnaro, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Smith JF, Luttrell RG, Greene JK, Tingle C. Early-season soybean as a trap crop for stink bugs (Heteroptera: Pentatomidae) in Arkansas' changing system of soybean production. Environ Entomol 2009; 38:450-8. [PMID: 19389295 DOI: 10.1603/022.038.0219] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Early-season soybean, Glycine max L. Merrill, was evaluated in Arkansas soybean fields as a trap crop for a complex of stink bug species that included Nezara viridula L., Acrosternum hilare (Say), and Euschistus servus (Say). Early-season soybean production systems (ESPSs) are composed of indeterminate soybean cultivars planted in April. In the first year of a 2-yr study, field-scale trap crops ( approximately 0.5-1.0 ha) of maturity group (MG) III and IV soybean were planted adjacent to production fields of MG V soybean. Stink bugs were attracted first to the ESPS trap crops and were twice treated with insecticide, yet damaging populations developed later in the MG V soybean adjacent to the trap crops. General sampling and observations of low stink bug densities in commercial fields of soybean and corn across the study area suggested that stink bugs were widely distributed across the agricultural landscape. These observations and the subsequent discovery of additional ESPS fields outside the study area suggested that developing populations in the adjacent MG V soybean probably did not originate from the trap crops. However the source of the populations colonizing MG V soybean could not be determined, and we concluded that the scale of future experiments should be increased to better control stink bugs dispersing from other ESPSs outside the study area. In the second year of the study, the experiment was expanded in size to a farm- or community-scale project where entire fields of ESPSs (8-32 ha) were used as trap crops. Insecticide was applied to the trap-crop fields and other fields of ESPSs within a 0.8-km radius of targeted response fields, yet again there was no apparent effect on subsequent populations of stink bugs in the MG V response fields. With the recent expansion of ESPSs in Arkansas, it may be difficult to use ESPSs as a trap crop to lower stink bug populations across large enough areas to suppress populations in late-season soybean. Also, multiple soybean cultivars are generally planted across a 2- or 3-mo period in Arkansas, which results in staggered soybean development across the landscape and extends the time period that soybean is attractive to colonizing stink bugs. Trap crops of ESPSs are only attractive for oviposition for up to 4-5 wk and cannot protect full-season soybean production systems (FSSPSs) for such an extended time period. This shift in production systems may limit the use of ESPS trap crops for management of stink bugs unless highly coordinated efforts are made to synchronize soybean maturity and control stink bugs in ESPSs across large geographic areas.
Collapse
Affiliation(s)
- J F Smith
- Department of Entomology and Plant Pathology, Mississippi State University, Box 9775, Mississippi State, MS 39762, USA.
| | | | | | | |
Collapse
|
26
|
Smith JF, Luttrell RG, Greene JK. Seasonal abundance, species composition, and population dynamics of stink bugs in production fields of early and late soybean in South Arkansas. J Econ Entomol 2009; 102:229-36. [PMID: 19253641 DOI: 10.1603/029.102.0132] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
From 2003 through 2007, densities of stink bugs were monitored weekly in 297 commercial production fields of early and late soybean, Glycine max L. Merrill, in southeast and southwest Arkansas. The goal of this research was to better understand seasonal abundance, species composition, and population dynamics of pentatomids as a benchmark reference for future management systems. Thirty-five percent of all the 25-sweep samples taken in soybean contained at least one stink bug specimen. The average density (mean +/- SEM) of stink bugs across all soybean samples was 1.84 +/- 0.06 per 25 sweeps. Overall, Nezara viridula L. was the most abundant species, although Euschistus serous (Say) was frequently found in soybean samples (18% of all samples). Peak densities of stink bugs in soybean were observed during the full-pod (R7) developmental stage. Approximately 25% of all soybean fields sampled had threshold densities (nine or more per 25 sweeps) at some time during the year, although 82 and 78% of fields in 2006 and 2007, respectively, reached threshold. At low densities (one to three stink bugs per 25 sweeps), E. serous comprised 50% of total stink bugs, but at high densities (> 71 stink bugs per 25 sweeps), N. viridula comprised 81% of total stink bugs. Piezodorus guildinii (Westwood) was observed as a pest of Arkansas soybean in 2005, and reproduction in soybean was documented in 2006 and 2007. Stink bugs seem to be a serious and increasingly important pest of soybean in southern Arkansas. Crop phenological development is a key factor in predicting colonization and population growth of stink bugs on Arkansas soybean, regardless of geographic region or type of soybean production system.
Collapse
Affiliation(s)
- J F Smith
- Department of Entomology and Plant Pathology, Mississippi State University, Box 9775, Mississippi State, MS 39762, USA.
| | | | | |
Collapse
|
27
|
Furniss CS, McClean MD, Smith JF, Bryan J, Applebaum KM, Nelson HH, Posner MR, Kelsey KT. Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use. Ann Oncol 2008; 20:534-41. [PMID: 19087986 DOI: 10.1093/annonc/mdn643] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
BACKGROUND The risk of head and neck squamous cell carcinoma (HNSCC) associated with common human papillomavirus types has not been well defined. METHODS We conducted a case-control study of 1034 individuals (486 incident cases diagnosed with HNSCC and 548 population-based controls matched to cases by age, gender, and town of residence) in Greater Boston, MA. Sera were tested for antibodies to human papillomavirus (HPV)6, HPV11, HPV16, and HPV18 L1. RESULTS HPV6 antibodies were associated with an increased risk of pharyngeal cancer [odds ratio (OR)=1.6, 1.0-2.5], controlling for smoking, drinking, and HPV16 seropositivity. In HPV16-seronegative subjects, high HPV6 titer was associated with an increased risk of pharyngeal cancer (OR=2.3, 1.1-4.8) and oral cancer (OR=1.9, 1.0-3.6), suggesting that the cancer risk associated with HPV6 is independent of HPV16. There was no association between smoking and alcohol use and HPV6 serostatus. Further, the risk of pharyngeal cancer associated with heavy smoking was different among HPV6-seronegative (OR 3.1, 2.0-4.8) and HPV6-seropositive subjects (OR=1.6, 0.7-3.5), while heavy drinking also appears to confer differing risk among HPV6-negative (OR 2.3, 1.5-3.7) and -positive subjects (OR=1.3, 0.6-2.9). CONCLUSIONS There may be interactions between positive serology and drinking and smoking, suggesting that the pathogenesis of human papillomavirus in HNSCC involves complex interactions with tobacco and alcohol exposure.
Collapse
Affiliation(s)
- C S Furniss
- Department of Environmental Health, Harvard School of Public Health, Boston, USA
| | | | | | | | | | | | | | | |
Collapse
|
28
|
|
29
|
Kamrud KI, Alterson KD, Andrews C, Copp LO, Lewis WC, Hubby B, Patel D, Rayner JO, Talarico T, Smith JF. Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats. PLoS One 2008; 3:e2709. [PMID: 18628938 PMCID: PMC2447172 DOI: 10.1371/journal.pone.0002709] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2008] [Accepted: 06/19/2008] [Indexed: 11/19/2022] Open
Abstract
Background The Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein (GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo. Methodology/Principal Findings The VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers. Conclusions/Significance We suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.
Collapse
Affiliation(s)
- Kurt I Kamrud
- AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Hubby B, Talarico T, Maughan M, Reap EA, Berglund P, Kamrud KI, Copp L, Lewis W, Cecil C, Norberg P, Wagner J, Watson A, Negri S, Burnett BK, Graham A, Smith JF, Chulay JD. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 2007; 25:8180-9. [PMID: 17961878 DOI: 10.1016/j.vaccine.2007.09.038] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2007] [Revised: 08/08/2007] [Accepted: 09/07/2007] [Indexed: 11/19/2022]
Abstract
We used a propagation-defective, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the hemagglutinin (HA) and neuraminidase (NA) proteins from influenza A/Wyoming/03/2003 (H3N2). Efficient production methods were scaled to produce pilot lots of HA VRP and NA VRP and clinical lots of HA VRP. HA VRP-induced high-titered antibody responses in mice, rabbits and rhesus macaques, as measured by ELISA or hemagglutination inhibition (HI) assays, and robust cellular immune responses in mice and rhesus macaques, as measured by IFN-gamma ELISPOT. NA VRP also induced cellular immune responses in mice. A toxicology study with HA VRP and NA VRP in rabbits showed no adverse effects in any parameter. These studies support clinical testing of alphavirus replicon vaccines for influenza.
Collapse
Affiliation(s)
- Bolyn Hubby
- AlphaVax, Inc., 2 Triangle Drive, Research Triangle Park, NC 27709, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
|
32
|
Nishimoto KP, Laust AK, Wang K, Kamrud KI, Hubby B, Smith JF, Nelson EL. Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells. Viral Immunol 2007; 20:88-104. [PMID: 17425424 DOI: 10.1089/vim.2006.0090] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Dendritic cells (DCs) consist of heterogeneous phenotypic populations and have diverse immunostimulatory functions dependent on both lineage and functional phenotype, but as exceptionally potent antigen-presenting cells, they are targets for generating effective antigen-specific immune responses. A promising replicon particle vector derived from Venezuelan equine encephalitis virus (VEE) has been reported to transduce murine footpad DCs. However, the receptive DC subset, the degree of restriction for this tropism, and the extent of conservation between rodents and humans have not been well characterized. Using fresh peripheral blood DCs, mononuclear cells, monocyte-derived macrophages, and monocyte-derived DCs, our results demonstrate conservation of VEE replicon particle (VRP) tropism for DCs between humans and rodents. We observed that a subset of immature myeloid DCs is the target population, and that VRP-transduced immature DCs retain intact functional capacity, for example, the ability to resist the cytopathic effects of VRP transduction and the capacity to acquire the mature phenotype. These studies support the demonstration of selective VRP tropism for human DCs and provide further insight into the biology of the VRP vector, its parent virus, and human DCs.
Collapse
Affiliation(s)
- Kevin P Nishimoto
- Molecular Biology and Biochemistry, School of Medicine, School of Biological Sciences, University of California, Irvine, Irvine, California 92697, USA
| | | | | | | | | | | | | |
Collapse
|
33
|
Kamrud KI, Custer M, Dudek JM, Owens G, Alterson KD, Lee JS, Groebner JL, Smith JF. Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 2007; 360:376-87. [PMID: 17156813 PMCID: PMC1885372 DOI: 10.1016/j.virol.2006.10.049] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2006] [Revised: 08/30/2006] [Accepted: 10/30/2006] [Indexed: 02/05/2023]
Abstract
Here we describe a system for promoterless analysis of putative internal ribosome entry site (IRES) elements using an alphavirus (family Togaviridae) replicon vector. The system uses the alphavirus subgenomic promoter to produce transcripts that, when modified to contain a spacer region upstream of an IRES element, allow analysis of cap-independent translation of genes of interest (GOI). If the IRES element is removed, translation of the subgenomic transcript can be reduced >95% compared to the same transcript containing a functional IRES element. Alphavirus replicons, used in this manner, offer an alternative to standard dicistronic DNA vectors or in vitro translation systems currently used to analyze putative IRES elements. In addition, protein expression levels varied depending on the spacer element located upstream of each IRES. The ability to modulate the level of expression from alphavirus vectors should extend the utility of these vectors in vaccine development.
Collapse
Affiliation(s)
- K I Kamrud
- AlphaVax, Inc., 2 Triangle Drive, Research Triangle Park, NC 27709-0307, USA.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Laust AK, Sur BW, Wang K, Hubby B, Smith JF, Nelson EL. VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model. Breast Cancer Res Treat 2007; 106:371-82. [PMID: 17351745 DOI: 10.1007/s10549-007-9517-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2007] [Accepted: 01/07/2007] [Indexed: 10/23/2022]
Abstract
The ability to overcome intrinsic tolerance to a strict "self" tumor-associated antigen (TAA) and successfully treat pre-existing tumor is the most stringent test for anti-tumor immunotherapeutic strategies. Although this capacity has been demonstrated in various models using complicated strategies that may not be readily translated into the clinical arena, straightforward antigen-specific immunotherapeutic strategies in the most stringent models of common epithelial cancers have largely failed to meet this standard. We employed an immunotherapeutic strategy using an alphavirus-based, virus-like replicon particle (VRP), which has in vivo tropism for dendritic cells, to elicit immune responses to the non-mutated TAA rat neu in an aggressive rat mammary tumor model. Using this VRP-based immunotherapeutic strategy targeting a single TAA, we generated effective anti-tumor immunity in the setting of pre-existing tumor resulting in the cure of 36% of rats over multiple experiments, P = 0.002. We also observed down-regulation of rat neu expression in tumors that showed initial responses followed by tumor escape with resumption of rapid tumor growth. These responses were accompanied by significant anti-tumor proliferative responses and CD8+ cellular tumor infiltrates, all of which were restricted to animals receiving the anti-neu immunotherapy. Together these data, obtained in a stringent "self" TAA model, indicate that the VRP-based antigen-specific immunotherapy elicits sufficiently potent immune responses to exert immunologic pressure, selection, and editing of the growing tumors, thus supporting the activity of this straightforward immunotherapy and suggesting that it is a promising platform upon which to build even more potent strategies.
Collapse
Affiliation(s)
- Amanda K Laust
- Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA
| | | | | | | | | | | |
Collapse
|
35
|
Hurst AM, Butler PA, Jenkins DG, Delahaye P, Wenander F, Ames F, Barton CJ, Behrens T, Bürger A, Cederkäll J, Clément E, Czosnyka T, Davinson T, de Angelis G, Eberth J, Ekström A, Franchoo S, Georgiev G, Görgen A, Herzberg RD, Huyse M, Ivanov O, Iwanicki J, Jones GD, Kent P, Köster U, Kröll T, Krücken R, Larsen AC, Nespolo M, Pantea M, Paul ES, Petri M, Scheit H, Sieber T, Siem S, Smith JF, Steer A, Stefanescu I, Syed NUH, Van de Walle J, Van Duppen P, Wadsworth R, Warr N, Weisshaar D, Zielińska M. Measurement of the sign of the spectroscopic quadrupole moment for the 2(1)+ state in 70Se: no evidence for oblate shape. Phys Rev Lett 2007; 98:072501. [PMID: 17359019 DOI: 10.1103/physrevlett.98.072501] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2006] [Indexed: 05/14/2023]
Abstract
Using a method whereby molecular and atomic ions are independently selected, an isobarically pure beam of 70Se ions was postaccelerated to an energy of 206 MeV using REX-ISOLDE. Coulomb-excitation yields for states in the beam and target nuclei were deduced by recording deexcitation gamma rays in the highly segmented MINIBALL gamma-ray spectrometer in coincidence with scattered particles in a silicon detector. At these energies, the Coulomb-excitation yield for the first 2+ state is expected to be strongly sensitive to the sign of the spectroscopic quadrupole moment through the nuclear reorientation effect. Experimental evidence is presented here for a prolate shape for the first 2+ state in 70Se, reopening the question over whether there are, as reported earlier, deformed oblate shapes near to the ground state in the light selenium isotopes.
Collapse
Affiliation(s)
- A M Hurst
- Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Schleiss MR, Lacayo JC, Belkaid Y, McGregor A, Stroup G, Rayner J, Alterson K, Chulay JD, Smith JF. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 2007; 195:789-98. [PMID: 17299708 DOI: 10.1086/511982] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2006] [Accepted: 09/21/2006] [Indexed: 11/03/2022] Open
Abstract
Development of a vaccine against congenital cytomegalovirus (CMV) infection is a major public health priority. We report the use of a propagation-defective, single-cycle, RNA replicon vector system, derived from an attenuated strain of the alphavirus Venezuelan equine encephalitis virus, to produce virus-like replicon particles (VRPs) expressing GP83, the guinea pig CMV (GPCMV) homolog of the human CMV pp65 phosphoprotein. Vaccination with VRP-GP83 induced antibodies and CD4(+) and CD8(+) T cell responses in GPCMV-seronegative female guinea pigs. Guinea pigs immunized with VRP-GP83 vaccine or with a VRP vaccine expressing influenza hemagglutinin (VRP-HA) were bred for pregnancy and subsequent GPCMV challenge during the early third trimester. Dams vaccinated with VRP-GP83 had improved pregnancy outcomes, compared with dams vaccinated with the VRP-HA control. For VRP-GP83-vaccinated dams, there were 28 live pups and 4 dead pups (13% mortality) among 10 evaluable litters, compared with 9 live pups and 12 dead pups (57% mortality) among 8 evaluable litters in the VRP-HA-vaccinated group (P<.001, Fisher's exact test). Improved pregnancy outcome was accompanied by reductions in maternal blood viral load, measured by real-time polymerase chain reaction. These results indicate that cell-mediated immune responses directed against a CMV matrix protein can protect against congenital CMV infection and disease.
Collapse
Affiliation(s)
- Mark R Schleiss
- Department of Pediatrics, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice. Vaccine 2006; 24:6886-92. [PMID: 16828936 DOI: 10.1016/j.vaccine.2006.06.004] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2006] [Revised: 06/05/2006] [Accepted: 06/07/2006] [Indexed: 11/16/2022]
Abstract
The development of multiagent vaccines offers the advantage of eliciting protection against multiple diseases with minimal inoculations over a shorter time span. We report here the results of using formulations of individual Venezuelan equine encephalitis (VEE) virus replicon-vectored vaccines against a bacterial disease, anthrax; a viral disease, Marburg fever; and against a toxin-mediated disease, botulism. The individual VEE replicon particles (VRP) expressed mature 83-kDa protective antigen (MAT-PA) from Bacillus anthracis, the glycoprotein (GP) from Marburg virus (MBGV), or the H(C) fragment from botulinum neurotoxin (BoNT H(C)). CBA/J mice inoculated with a mixture of VRP expressing BoNT H(C) serotype C (BoNT/C H(C)) and MAT-PA were 80% protected from a B. anthracis (Sterne strain) challenge and then 100% protected from a sequential BoNT/C challenge. Swiss mice inoculated with individual VRP or with mixtures of VRP vaccines expressing BoNT H(C) serotype A (BoNT/A H(C)), MAT-PA, and MBGV-GP produced antibody responses specific to the corresponding replicon-expressed protein. Combination of the different VRP vaccines did not diminish the antibody responses measured for Swiss mice inoculated with formulations of two or three VRP vaccines as compared to mice that received only one VRP vaccine. Swiss mice inoculated with VRP expressing BoNT/A H(C) alone or in combination with VRP expressing MAT-PA and MBGV GP, were completely protected from a BoNT/A challenge. These studies demonstrate the utility of combining individual VRP vaccines into multiagent formulations for eliciting protective immune responses to various types of diseases.
Collapse
Affiliation(s)
- John S Lee
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Buckingham KL, Stone PR, Smith JF, Chamley LW. Antiphospholipid antibodies in serum and follicular fluid--is there a correlation with IVF implantation failure? Hum Reprod 2005; 21:728-34. [PMID: 16253967 DOI: 10.1093/humrep/dei369] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Antiphospholipid antibodies (aPLs) are associated with infertility, but the mechanism underlying this statistical association is currently obscure. We aimed to investigate the finding that aPLs are concentrated in follicular fluid and to establish if this is associated with a poorer outcome from IVF. METHODS AND RESULTS In 19.2% of 99 women undergoing IVF, at least one aPL was detected in their serum and/or follicular fluids, but the antibody levels in follicular fluid were not higher than in serum. Women with aPLs had a lower implantation rate (14%) than women without these antibodies (24.1%), but this difference was not significant (P=0.127). There was also a non-significant reduction in the live birth rate for women with aPLs. In a parallel investigation, 10 sheep immunized with beta2 glycoprotein I (beta2GPI) or irrelevant control antigens showed strong immune responses, but there were no significant differences between the levels of antibodies in the follicular fluid or serum from beta2GPI or control immunized sheep. CONCLUSION aPLs do not appear to be selectively concentrated in follicular fluids and, when present, do not adversely affect the reproductive outcome of women undergoing IVF.
Collapse
Affiliation(s)
- K L Buckingham
- Department of Obstetrics and Gynaecology, University of Auckland, and Fertility Plus, Greenlane Clinical Centre, Private Bag 92189, Auckland 1003, New Zealand.
| | | | | | | |
Collapse
|
39
|
Tervit HR, Adams SL, Roberts RD, McGowan LT, Pugh PA, Smith JF, Janke AR. Successful cryopreservation of Pacific oyster (Crassostrea gigas) oocytes. Cryobiology 2005; 51:142-51. [PMID: 16084505 DOI: 10.1016/j.cryobiol.2005.06.001] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2005] [Revised: 06/16/2005] [Accepted: 06/17/2005] [Indexed: 10/25/2022]
Abstract
Protocols for cryopreservation of sperm and oocytes would provide the ultimate control over parental crosses in selective breeding programmes. Sperm freezing is routine for many species, but oocyte freezing remains problematic, with virtually zero success in aquatic species to date. This paper describes the development of a successful protocol for cryopreserving high concentrations of Pacific oyster (Crassostrea gigas) oocytes. Ethylene glycol (10%) and dimethyl sulfoxide (15%) were found to be the most effective cryoprotectants resulting in post-thaw fertilization rates of 51.0+/-8.0 and 45.1+/-8.3%, respectively. Propylene glycol was less effective and methanol resulted in zero fertilization post-thaw. The use of Milli-Q water rather than seawater as a base medium significantly improved fertilization (20.4+/-3.0 and 8.7+/-2.2%, respectively) as did the inclusion of a 5 min isothermal hold at -10 or -12 degrees C (35.9+/-5.0 and 31.9+/-4.6%, respectively). The optimal cooling rate post-hold was 0.3 degrees C min(-1), with virtually zero post-thaw fertilization with cooling rates of 3 and 6 degrees C min(-1). Using an optimized protocol, post-thaw fertilization rates for oocytes from eight individual females ranged from 0.8 to 74.5% and D-larval yields from 0.1 to 30.1%. For three individuals, larvae were reared through to spat. Development of D-larvae to eyed larvae and spat was similar for larvae produced from unfrozen (24.8+/-4.1% developed to eyed larvae and 16.5+/-3.2% to spat) and cryopreserved (28.4+/-0.6 and 18.7+/-0.5%, respectively) oocytes. The ability to cryopreserve large quantities of oyster oocytes represents a major advance in cryobiology and selective breeding.
Collapse
Affiliation(s)
- H R Tervit
- AgResearch Limited, Private Bag 3123, Hamilton, New Zealand
| | | | | | | | | | | | | |
Collapse
|
40
|
Nelson EL, Prieto D, Alexander TG, Pushko P, Lofts LA, Rayner JO, Kamrud KI, Fralish B, Smith JF. Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model. Breast Cancer Res Treat 2003; 82:169-83. [PMID: 14703064 DOI: 10.1023/b:brea.0000004373.09678.bb] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Many tumor-associated antigens (TAAs) represent 'self' antigens and as such, are subject to the constraints of immunologic tolerance. There are significant barriers to eliciting anti-tumor immune responses of sufficient magnitude. We have taken advantage of a Venezuelan equine encephalitis-derived alphavirus replicon vector system with documented in vivo tropism for immune system dendritic cells. We have overcome the intrinsic tolerance to the 'self' TAA rat neu and elicited an effective anti-tumor immune response using this alphavirus replicon vector system and a designed target antigen in a rigorous rat mammary tumor model. We have demonstrated the capacity to generate 50% protection in tumor challenge experiments (p = 0.004) and we have confirmed the establishment of immunologic memory by both second tumor challenge and Winn Assay (p = 0.009). Minor antibody responses were identified and supported the establishment of T helper type 1 (Th1) anti-tumor immune responses by isotype. Animals surviving in excess of 300 days with established effective anti-tumor immunity showed no signs of autoimmune phenomena. Together these experiments support the establishment of T lymphocyte dependent, Th1-biased anti-tumor immune responses to a non-mutated 'self' TAA in an aggressive tumor model. Importantly, this tumor model is subject to the constraints of immunologic tolerance present in animals with normal developmental, temporal, and anatomical expression of a non-mutated TAA. These data support the continued development and potential clinical application of this alphaviral replicon vector system and the use of appropriately designed target antigen sequences for anti-tumor immunotherapy.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Antigens, Neoplasm/immunology
- Disease Models, Animal
- Encephalitis Virus, Venezuelan Equine/genetics
- Female
- Genetic Vectors/immunology
- Genetic Vectors/therapeutic use
- Humans
- Immunization
- Mammary Neoplasms, Experimental/immunology
- Mammary Neoplasms, Experimental/therapy
- Molecular Sequence Data
- Neoplasm Proteins/immunology
- Rats
- Rats, Inbred F344
- Receptor, ErbB-2/chemistry
- Receptor, ErbB-2/genetics
- Receptor, ErbB-2/immunology
- Replicon/immunology
- Self Tolerance
- Vaccines, Synthetic/immunology
Collapse
Affiliation(s)
- Edward L Nelson
- Department of Medicine, Division of Hematology/Oncology, School of Medicine and Molecular Biology and Biochemistry, University of California, Irvine, CA 97697-4060, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Pattison LK, Cullen DM, Smith JF, Fletcher AM, Walker PM, El-Masri HM, Podolyák Z, Wood RJ, Scholey C, Wheldon C, Mukherjee G, Balabanski D, Djongolov M, Dalsgaard T, Thisgaard H, Sletten G, Kondev F, Jenkins D, Lane GJ, Lee IY, Macchiavelli AO, Frauendorf S, Almehed D. Multiphonon vibrations at high angular momentum in 182 Os. Phys Rev Lett 2003; 91:182501. [PMID: 14611278 DOI: 10.1103/physrevlett.91.182501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2002] [Indexed: 05/24/2023]
Abstract
Evidence is presented for multiphonon excitations based on a high-spin (25 Planck) intrinsic state in the deformed nucleus 182 Os. Angular momentum generation by this mode competes with collective rotation. The experimental data are compared with tilted-axis cranking calculations, supporting the vibrational interpretation. However, the lower experimental energies provide evidence that more complex interactions of states are playing a role.
Collapse
Affiliation(s)
- L K Pattison
- Schuster Laboratory, University of Manchester, Manchester M13 9PL, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Abstract
The central objective of this research was to test molecularly defined, live attenuated Venezuelan equine encephalitis virus (VEEV) vaccine candidates that were produced through precise genetic manipulation of rationally selected viral nucleotide sequences. Molecular clones of vaccine candidates were constructed by inserting either three independently attenuating mutations or a PE2 cleavage-signal mutation with a second-site resuscitating mutation into full-length cDNA clones. Vaccine candidate viruses were recovered through DNA transcription and RNA transfection of cultured cells, and assessed in rodent and non-human primate models. Based on results from this assessment, one of the PE2 cleavage-signal mutants, V3526, was determined to be the best vaccine candidate for further evaluation for human use.
Collapse
MESH Headings
- Animals
- Antibodies, Viral/analysis
- Antibodies, Viral/biosynthesis
- Cloning, Molecular
- Cricetinae
- DNA, Complementary/immunology
- Encephalitis Virus, Venezuelan Equine/genetics
- Encephalitis Virus, Venezuelan Equine/immunology
- Encephalitis Virus, Venezuelan Equine/pathogenicity
- Encephalomyelitis, Venezuelan Equine/prevention & control
- Female
- Macaca fascicularis
- Mesocricetus
- Mice
- Mice, Inbred C57BL
- Mutation/immunology
- Protein Engineering
- Vaccines, Attenuated/immunology
- Viral Vaccines/genetics
- Viral Vaccines/immunology
Collapse
Affiliation(s)
- William D Pratt
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011, USA.
| | | | | | | |
Collapse
|
43
|
Abstract
Chimeric cDNA clones, pMWE1000 and pMWE2000, differing by five nucleotides at their 5' termini, were constructed of the 5' two-thirds of the western equine encephalitis (WEE) virus genome (encoding nonstructural proteins) and the 3' one-third of the eastern equine encephalitis (EEE) virus genome (encoding structural proteins). The WEE virus sequences were derived from full-length cDNA clones, pWE1000 and pWE2000, which were isogenic except for five nucleotide differences at their 5' termini and were responsible for significant differences in mouse virulence. Each cDNA clone was placed downstream from a T7 promoter to allow in vitro transcription of full-length RNA. Transfection of BHK-21 cells with the chimeric RNA by electroporation gave rise to high-titer infectious virus. The in vitro characteristics of each chimera virus were determined by electrophoretic analysis of its structural proteins, plaque morphology, neutralization characteristics, replication kinetics, and rate of viral RNA synthesis. With the exception of plaque morphology, the in vitro characteristics of MWE1000 and MWE2000 were indistinguishable from the parental EEE virus. Subcutaneous inoculation of 5-week-old C57BL/6 mice with varying doses of MWE1000 or MWE2000 virus demonstrated that both chimeric viruses were significantly attenuated compared to the parental WEE virus (Cba 87) and EEE virus (PE-6). Animals infected with 10(5) PFU or more of either MWE1000 or MWE2000 were completely protected from lethal challenge with the virulent EEE virus, FL91-4679, but were not protected from virulent WEE virus Cba 87 challenge. Construction of viable virus chimeras often results in attenuated viruses that may hold promise as genetically engineered alphavirus vaccine candidates (R. J. Kuhn, D. E. Griffin, K. E. Owen, H. G. M. Niesters, and J. H. Strauss, 1996, J. Virol. 70, 7900-7909).
Collapse
MESH Headings
- Animals
- Base Sequence
- Cell Line
- Cloning, Molecular
- Cricetinae
- DNA, Complementary/genetics
- Encephalitis Virus, Eastern Equine/genetics
- Encephalitis Virus, Eastern Equine/immunology
- Encephalitis Virus, Eastern Equine/pathogenicity
- Encephalitis Virus, Western Equine/genetics
- Encephalitis Virus, Western Equine/immunology
- Encephalitis Virus, Western Equine/pathogenicity
- Encephalomyelitis, Equine/immunology
- Encephalomyelitis, Equine/prevention & control
- Encephalomyelitis, Equine/virology
- Female
- Mice
- Mice, Inbred C57BL
- Molecular Sequence Data
- Recombinant Fusion Proteins/genetics
- Recombinant Fusion Proteins/immunology
- Viral Vaccines/genetics
- Viral Vaccines/immunology
Collapse
Affiliation(s)
- Randal J Schoepp
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.
| | | | | |
Collapse
|
44
|
Ludwig GV, Calle PP, Mangiafico JA, Raphael BL, Danner DK, Hile JA, Clippinger TL, Smith JF, Cook RA, McNamara T. An outbreak of West Nile virus in a New York City captive wildlife population. Am J Trop Med Hyg 2002; 67:67-75. [PMID: 12363067 DOI: 10.4269/ajtmh.2002.67.67] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
An outbreak of West Nile virus (WNV) in and around New York City during the late summer of 1999 was the cause of extensive mortality among free-ranging birds. Within the Bronx Zoo/Wildlife Conservation Park, viral activity was also observed and produced some morbidity and mortality among specimens in the zoo's bird collection and probably caused morbidity in at least one specimen from the zoo's mammal collection. To determine the extent of the outbreak and attempt to ascertain the temporal appearance of virus within the park, a serologic survey of birds and mammals was performed. The survey showed that 34% of tested birds (125 of 368; 124 species) were positive for antibody to WNV. The virus caused a disease to infection ratio of 22% (27 of 125) among birds with a 70% (19 of 27) case fatality rate. In contrast, only 8% of the mammals (9 of 117; 35 species) possessed antibody to WNV and there was no virus-associated mortality. Testing of banked and fresh sera obtained from both birds and mammals revealed that there was no evidence of WNV circulation before the 1999 outbreak and that birds introduced into the park were not the source of the New York outbreak. West Nile virus RNA was detected in tissues from one bird that died in February 2000, long after the end of the mosquito transmission season. The potential importance of zoologic parks as possible sentinels for emerging diseases is discussed.
Collapse
Affiliation(s)
- George V Ludwig
- Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Lee JS, Dyas BK, Nystrom SS, Lind CM, Smith JF, Ulrich RG. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J Infect Dis 2002; 185:1192-6. [PMID: 11930333 DOI: 10.1086/339677] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2001] [Revised: 12/07/2001] [Indexed: 11/03/2022] Open
Abstract
A candidate vaccine against staphylococcal enterotoxin B (SEB) was developed using a Venezuelan equine encephalitis (VEE) virus vector. This vaccine is composed of a self-replicating RNA, termed "replicon," containing the VEE nonstructural genes and cis-acting elements and a gene encoding mutagenized SEB (mSEB). Cotransfection of baby hamster kidney cells with the mSEB replicon and 2 helper RNA molecules resulted in the release of propagation-deficient mSEB-VEE replicon particles (mSEB-VRPs). Mice inoculated subcutaneously with mSEB-VRPs were protected (15 of 20 mice) from a challenge with 5 median lethal dose units of wild-type (wt) SEB. T cells from mice vaccinated with mSEB-VRP responded normally both in vitro to wt SEB and in recall response to the inactivated mSEB polypeptide. The profile of cytokines measured after challenge with wt SEB suggested that the mode of protection was predominantly Th1 dependent. Our results suggest that the VEE replicon is a practical and convenient model system for evaluating efficacy of vaccines for the control of bacterial diseases.
Collapse
Affiliation(s)
- John S Lee
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702, USA.
| | | | | | | | | | | |
Collapse
|
46
|
Shoemaker MO, Tammariello R, Crise B, Bouhaouala SS, Knudson GB, Jackson WE, Ludwig GV, Smith JF. Combined effects of Venezuelan equine encephalitis IIIA virus and gamma irradiation in mice. Mil Med 2001; 166:88-9. [PMID: 11778450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023] Open
Abstract
The combined effects of injury from exposure to ionizing radiation and the potential biological warfare agent Venezuelan equine encephalitis (VEE) virus remain largely unknown. To study these effects, 4- to 5-week-old B6D2F1/J female mice were given a sublethal whole-body 7 Gy dose of 60Co gamma-photon radiation followed 48 hours later by aerosol or intraperitoneal challenge with enzootic VEE IIIA virus. Survival was observed for 30 days. A single sublethal 7 Gy dose of gamma radiation reduced the LD50/30 of VEE IIIA virus, in intraperitoneal challenged mice by a factor of 10(4) from 1.1 x 10(6) plaque-forming units (pfu) to 1 x 10(2) pfu, and in aerosol challenged mice, by a factor of 5 from 70 pfu to 14 pfu. These findings further confirm there is a combined effect of exposure to ionizing radiation and biological warfare agents, which could be devastating to unprotected populations and thus should be investigated further.
Collapse
Affiliation(s)
- M O Shoemaker
- Armed Forces Radiobiology Research Institute, Bethesda, Maryland 20889, USA.
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Shoemaker MO, Tammariello R, Crise B, Bouhaouala SS, Knudson GB, Jackson WE, Ludwig GV, Smith JF. Combined Effects of Venezuelan Equine Encephalitis IIIA Virus and Gamma Irradiation in Mice. Mil Med 2001. [DOI: 10.1093/milmed/166.suppl_2.88] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - Ralph Tammariello
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702
| | - Bruce Crise
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702
| | | | | | | | - George V. Ludwig
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702
| | - Jonathan F. Smith
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702
| |
Collapse
|
48
|
Hevey M, Negley D, VanderZanden L, Tammariello RF, Geisbert J, Schmaljohn C, Smith JF, Jahrling PB, Schmaljohn AL. Marburg virus vaccines: comparing classical and new approaches. Vaccine 2001; 20:586-93. [PMID: 11672925 DOI: 10.1016/s0264-410x(01)00353-x] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
An effort to develop a safe and effective vaccine for Marburg virus (MBGV), one of the filoviruses known to cause high mortality rates in humans, led us to compare directly some of the merits of modern versus classical vaccine approaches for this agent. Prior work had established the MBGV-glycoprotein (GP), the only known virion surface antigen, as a candidate for inclusion in a vaccine. In this study, we vaccinated groups of Hartley guinea pigs with killed MBGV, live attenuated MBGV, soluble MBGV-GP expressed by baculovirus recombinants, MBGV-GP delivered as a DNA vaccine, or MBGV-GP delivered via an alphavirus RNA replicon. Serological responses were evaluated, and animals were challenged with a lethal dose of MBGV given either subcutaneously or via aerosol. Killed MBGV and replicon-delivered MBGV-GP were notably immunogenic and protective against MBGV, but results did not exclude any approach and suggested a role for DNA vaccines in immunological priming.
Collapse
Affiliation(s)
- M Hevey
- Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Tak T, Smith JF. Hypersensitivity to warfarin in a patient with a mechanical aortic prosthesis. J Heart Valve Dis 2001; 10:832-4. [PMID: 11767195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
The case of a patient with a prosthetic aortic valve and warfarin hypersensitivity is presented. On rechallenging the patient with warfarin, a spongiotic dermatitis with heavy superficial perivascular lymphocytic infiltrates with eosinophils was seen. The patient was finally discharged on aspirin therapy alone and is doing well to date. Warfarin hypersensitivity is rare, and only incidental reports exist regarding its incidence and management. It is conceivable that newer antiplatelet agents, whether alone or in combination with aspirin, will provide better control of thromboembolic events in patients with warfarin intolerance.
Collapse
Affiliation(s)
- T Tak
- Department of Medicine, Scott & White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, The Texas A&M University System Health Science Center College of Medicine, Temple 54449, USA
| | | |
Collapse
|
50
|
Lee JS, Pushko P, Parker MD, Dertzbaugh MT, Smith LA, Smith JF. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun 2001; 69:5709-15. [PMID: 11500447 PMCID: PMC98687 DOI: 10.1128/iai.69.9.5709-5715.2001] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A candidate vaccine against botulinum neurotoxin serotype A (BoNT/A) was developed by using a Venezuelan equine encephalitis (VEE) virus replicon vector. This vaccine vector is composed of a self-replicating RNA containing all of the VEE nonstructural genes and cis-acting elements and also a heterologous immunogen gene placed downstream of the subgenomic 26S promoter in place of the viral structural genes. In this study, the nontoxic 50-kDa carboxy-terminal fragment (H(C)) of the BoNT/A heavy chain was cloned into the replicon vector (H(C)-replicon). Cotransfection of BHK cells in vitro with the H(C)-replicon and two helper RNA molecules, the latter encoding all of the VEE structural proteins, resulted in the assembly and release of propagation-deficient, H(C) VEE replicon particles (H(C)-VRP). Cells infected with H(C)-VRP efficiently expressed this protein when analyzed by either immunofluorescence or by Western blot. To evaluate the immunogenicity of H(C)-VRP, mice were vaccinated with various doses of H(C)-VRP at different intervals. Mice inoculated subcutaneously with H(C)-VRP were protected from an intraperitoneal challenge of up to 100,000 50% lethal dose units of BoNT/A. Protection correlated directly with serum enzyme-linked immunosorbent assay titers to BoNT/A. The duration of the immunity achieved was tested at 6 months and at 1 year postvaccination, and mice challenged at these times remained refractory to challenge with BoNT/A.
Collapse
Affiliation(s)
- J S Lee
- Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011, USA.
| | | | | | | | | | | |
Collapse
|